Ausgabe 4/2007
Inhalt (11 Artikel)
Necrostatin: A Potentially Novel Cardioprotective Agent?
Christopher C. T. Smith, Sean M. Davidson, Shiang Y. Lim, James C. Simpkin, John S. Hothersall, Derek M. Yellon
Myocardial Ischaemia-reperfusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In Vitro Rat Heart and may Involve the p70s6K Pathway
Amal K. Bose, Mihaela M. Mocanu, Richard D. Carr, Derek M. Yellon
The Effect of Hydrogen Peroxide in Human Internal Thoracic Arteries: Role of Potassium Channels, Nitric Oxide and Cyclooxygenase Products
Cahit Nacitarhan, Zeliha Bayram, Bilsen Eksert, Coskun Usta, Ilhan Golbasi, Sadi S. Ozdem
Effects of Levosimendan on Quality of Life and Emotional Stress in Advanced Heart Failure Patients
John T. Parissis, Constantinos Papadopoulos, Maria Nikolaou, Vassiliki Bistola, Dimitrios Farmakis, Ioannis Paraskevaidis, Gerasimos Filippatos, Dimitrios Kremastinos
ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial
M. L. Bots, W. J. Remme, T. F. Lüscher, K. M. Fox, M. Bertrand, R. Ferrari, M. L. Simoons, D. E. Grobbee
Predictors of Adherence to Statins for Primary Prevention
Devin M. Mann, John P. Allegrante, Sundar Natarajan, Ethan A. Halm, Mary Charlson
Potential Effects of Angiotensin II Receptor Blockers on Glucose Tolerance and Adiponectin Levels in Hypertensive Patients
Shinji Makita, Akihiko Abiko, Yujirou Naganuma, Yoshiteru Moriai, Motoyuki Nakamura